In July 2005, SFMS assisted in achieving a settlement in the Average Wholesale Price Litigation between the State of Connecticut (the “State”) and pharmaceutical manufacturer, Dey, Inc. (“Dey”). SFMS represented the State in the action against Dey arising under the Connecticut Unfair Trade Practices Act alleging the manipulation of the average wholesale price of certain prescription drugs.
The net amount of cash paid to the State of Connecticut, after legal fees and money remitted to the federal government, is $900,000.00. In addition, Dey will donate pharmaceuticals valued at $800,000.00 to certain Connecticut community health care centers and to free clinics maintained by the AmeriCares Foundation. These donated drugs will be made available to medically underserved populations of patients in the State of Connecticut.
SFMS continues to assist the Attorney General in prosecuting similar actions against the following pharmaceutical manufactures: Aventis Pharmaceuticals, Pharmacia Corporation, GlaxoSmithKline P.L.C. et al., Warrick Pharmaceuticals Corporation (Schering Corporation and Schering-Plough Corporation), and Boehringer Ingelheim Roxane, Inc. (f/k/a Roxane Laboratories, Inc.).